Yahoo Finance's Julia La Roche sits down with executive chairman and former CEO of Starbucks Howard Schultz
|Bid||1.21 x 4600|
|Ask||1.39 x 800|
|Day's Range||1.27 - 1.35|
|52 Week Range||0.79 - 3.65|
|PE Ratio (TTM)||-0.86|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Investors in Regulus Therapeutics Inc. (RGLS) need to pay close attention to the stock based on moves in the options market lately.
Q2 2017 Regulus Therapeutics Inc Earnings Call
The San Diego-based company said it had a loss of 41 cents per share. The results did not meet Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was ...